Stage IV Adult Lymphoblastic Lymphoma Completed Phase 1 / 2 Trials for Mechlorethamine (DB00888)

IndicationStatusPhase
DBCOND0028716 (Stage IV Adult Lymphoblastic Lymphoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01035463Lenalidomide as Maintenance Therapy After Combination Chemotherapy With or Without Rituximab and Stem Cell Transplant in Treating Patients With Persistent or Recurrent Non-Hodgkin Lymphoma That Is Resistant to ChemotherapyTreatment